The skin biopsy market size has grown strongly in recent years. It will grow from $1.86 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increase in skin cancer incidence, growth in dermatology clinics, adoption of outpatient diagnostics, availability of biopsy instruments, awareness of early diagnosis.
The skin biopsy market size is expected to see strong growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to rising melanoma cases, AI-enabled diagnostics adoption, expansion of tele-dermatology, aging population, growth in cosmetic dermatology. Major trends in the forecast period include minimally invasive biopsy techniques, dermatology diagnostic expansion, punch and shave biopsy preference, outpatient diagnostic procedures, ai-assisted pathology integration.
The rise in healthcare expenditure is also expected to contribute to the growth of the skin biopsy market. Healthcare expenditure refers to the total financial resources allocated to medical services, treatments, infrastructure, research, and public health programs aimed at improving health outcomes. A key reason for this increase is the growing number of chronic health conditions, which often require long-term care and costly interventions. Greater investment in healthcare leads to broader access to advanced diagnostic tools and expanded dermatological services. This supports early and accurate diagnosis of skin conditions and enhances patient care and overall health system performance. For instance, in May 2024, the Office for National Statistics, a government organization in the United Kingdom, reported a five point six percent increase in healthcare spending during 2023, compared to a zero point nine percent increase in the prior year. Consequently, the growth in healthcare expenditure is playing a significant role in the development of the skin biopsy market.
Major companies operating in the skin biopsy market are concentrating on the development of advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic precision and the quality of tissue samples. Semi-automatic biopsy instruments are engineered to enable controlled and accurate tissue collection, increasing the chances of a correct diagnosis and allowing pathologists to conduct thorough analyses. For example, in May 2023, Argon Medical Devices, a US-based company specializing in interventional and oncology device solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device provides enhanced tissue volume and is offered in a comprehensive range of lengths and gauge sizes to accommodate different clinical requirements. It is a disposable, next-generation instrument developed with input from healthcare professionals to address clinical demands. The SuperCore Advantage enables physicians to obtain larger tissue samples with confidence, ensures precise and consistent biopsy performance, and complements Argon’s existing product lineup, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This launch further reinforces Argon’s position as a prominent supplier of soft tissue biopsy devices while contributing to improved patient outcomes.
In April 2023, Aurora Diagnostics LLC, a US-based provider of anatomic pathology and diagnostic laboratory services, completed the acquisition of DermPath New England, LLC, for an undisclosed sum. Through this acquisition, Aurora Diagnostics broadened its nationwide dermatopathology network, reinforcing diagnostic expertise and expanding service reach for physicians who depend on timely and precise skin biopsy analysis. DermPath New England is a US-based dermatopathology laboratory specializing in comprehensive diagnostic assessment of skin biopsy samples for referring healthcare providers.
Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex.
North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the skin biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs for imported biopsy instruments, blades, and pathology consumables. North America and Europe are most affected due to reliance on precision surgical tools. Hospitals and dermatology clinics face procurement cost pressure, while tariffs are promoting domestic manufacturing of biopsy devices.
The skin biopsy market research report is one of a series of new reports that provides skin biopsy market statistics, including skin biopsy industry global market size, regional shares, competitors with a skin biopsy market share, detailed skin biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the skin biopsy industry. This skin biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A skin biopsy is a medical procedure in which a small sample of skin tissue is removed for diagnostic or research purposes. It is used to diagnose skin conditions, including infections, inflammatory disorders, and skin cancers, by examining the cellular structure of the tissue. This procedure helps clinicians determine the nature, severity, and appropriate treatment for various skin abnormalities.
The primary types of skin biopsy are excisional biopsy, incisional biopsy, punch biopsy, shave biopsy, and needle biopsy. Excisional biopsy involves surgically removing an entire lump, lesion, or suspicious tissue area along with a margin of normal surrounding tissue for microscopic examination. Procedure types include surgical biopsy, image-guided biopsy, dermatoscopic biopsy, and endoscopic biopsy. Applications include dermatology, oncology, pathology, clinical research, and cosmetic procedures. Key end-users include hospitals, ambulatory surgical centers (ASCs), diagnostic laboratories, research institutions, and dermatology clinics.
The skin biopsy market includes revenues earned by entities through skin tissue collection procedures, histopathological examination, molecular and immunohistochemistry testing, diagnostic pathology reporting services, and follow-up consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The skin biopsy market size is expected to see strong growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to rising melanoma cases, AI-enabled diagnostics adoption, expansion of tele-dermatology, aging population, growth in cosmetic dermatology. Major trends in the forecast period include minimally invasive biopsy techniques, dermatology diagnostic expansion, punch and shave biopsy preference, outpatient diagnostic procedures, ai-assisted pathology integration.
The rise in healthcare expenditure is also expected to contribute to the growth of the skin biopsy market. Healthcare expenditure refers to the total financial resources allocated to medical services, treatments, infrastructure, research, and public health programs aimed at improving health outcomes. A key reason for this increase is the growing number of chronic health conditions, which often require long-term care and costly interventions. Greater investment in healthcare leads to broader access to advanced diagnostic tools and expanded dermatological services. This supports early and accurate diagnosis of skin conditions and enhances patient care and overall health system performance. For instance, in May 2024, the Office for National Statistics, a government organization in the United Kingdom, reported a five point six percent increase in healthcare spending during 2023, compared to a zero point nine percent increase in the prior year. Consequently, the growth in healthcare expenditure is playing a significant role in the development of the skin biopsy market.
Major companies operating in the skin biopsy market are concentrating on the development of advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic precision and the quality of tissue samples. Semi-automatic biopsy instruments are engineered to enable controlled and accurate tissue collection, increasing the chances of a correct diagnosis and allowing pathologists to conduct thorough analyses. For example, in May 2023, Argon Medical Devices, a US-based company specializing in interventional and oncology device solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device provides enhanced tissue volume and is offered in a comprehensive range of lengths and gauge sizes to accommodate different clinical requirements. It is a disposable, next-generation instrument developed with input from healthcare professionals to address clinical demands. The SuperCore Advantage enables physicians to obtain larger tissue samples with confidence, ensures precise and consistent biopsy performance, and complements Argon’s existing product lineup, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This launch further reinforces Argon’s position as a prominent supplier of soft tissue biopsy devices while contributing to improved patient outcomes.
In April 2023, Aurora Diagnostics LLC, a US-based provider of anatomic pathology and diagnostic laboratory services, completed the acquisition of DermPath New England, LLC, for an undisclosed sum. Through this acquisition, Aurora Diagnostics broadened its nationwide dermatopathology network, reinforcing diagnostic expertise and expanding service reach for physicians who depend on timely and precise skin biopsy analysis. DermPath New England is a US-based dermatopathology laboratory specializing in comprehensive diagnostic assessment of skin biopsy samples for referring healthcare providers.
Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex.
North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the skin biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs for imported biopsy instruments, blades, and pathology consumables. North America and Europe are most affected due to reliance on precision surgical tools. Hospitals and dermatology clinics face procurement cost pressure, while tariffs are promoting domestic manufacturing of biopsy devices.
The skin biopsy market research report is one of a series of new reports that provides skin biopsy market statistics, including skin biopsy industry global market size, regional shares, competitors with a skin biopsy market share, detailed skin biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the skin biopsy industry. This skin biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A skin biopsy is a medical procedure in which a small sample of skin tissue is removed for diagnostic or research purposes. It is used to diagnose skin conditions, including infections, inflammatory disorders, and skin cancers, by examining the cellular structure of the tissue. This procedure helps clinicians determine the nature, severity, and appropriate treatment for various skin abnormalities.
The primary types of skin biopsy are excisional biopsy, incisional biopsy, punch biopsy, shave biopsy, and needle biopsy. Excisional biopsy involves surgically removing an entire lump, lesion, or suspicious tissue area along with a margin of normal surrounding tissue for microscopic examination. Procedure types include surgical biopsy, image-guided biopsy, dermatoscopic biopsy, and endoscopic biopsy. Applications include dermatology, oncology, pathology, clinical research, and cosmetic procedures. Key end-users include hospitals, ambulatory surgical centers (ASCs), diagnostic laboratories, research institutions, and dermatology clinics.
The skin biopsy market includes revenues earned by entities through skin tissue collection procedures, histopathological examination, molecular and immunohistochemistry testing, diagnostic pathology reporting services, and follow-up consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Skin Biopsy Market Characteristics
3. Skin Biopsy Market Supply Chain Analysis
4. Global Skin Biopsy Market Trends and Strategies
5. Skin Biopsy Market Analysis of End Use Industries
7. Global Skin Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Skin Biopsy Total Addressable Market (TAM) Analysis for the Market
9. Skin Biopsy Market Segmentation
2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than or Equal to (=) 5 Millimeter (mm) Punch
10. Skin Biopsy Market Regional and Country Analysis
11. Asia-Pacific Skin Biopsy Market
12. China Skin Biopsy Market
13. India Skin Biopsy Market
14. Japan Skin Biopsy Market
15. Australia Skin Biopsy Market
16. Indonesia Skin Biopsy Market
17. South Korea Skin Biopsy Market
18. Taiwan Skin Biopsy Market
19. South East Asia Skin Biopsy Market
20. Western Europe Skin Biopsy Market
21. UK Skin Biopsy Market
22. Germany Skin Biopsy Market
23. France Skin Biopsy Market
24. Italy Skin Biopsy Market
25. Spain Skin Biopsy Market
26. Eastern Europe Skin Biopsy Market
27. Russia Skin Biopsy Market
28. North America Skin Biopsy Market
29. USA Skin Biopsy Market
30. Canada Skin Biopsy Market
31. South America Skin Biopsy Market
32. Brazil Skin Biopsy Market
33. Middle East Skin Biopsy Market
34. Africa Skin Biopsy Market
36. Skin Biopsy Market Competitive Landscape and Company Profiles
37. Skin Biopsy Market Other Major and Innovative Companies
40. Skin Biopsy Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Skin Biopsy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses skin biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for skin biopsy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The skin biopsy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type Of Biopsy: Excisional Biopsy; Incisional Biopsy; Punch Biopsy; Shave Biopsy2) By Application: Dermatology; Oncology; Clinical Research
3) By End-User: Hospitals; Ambulatory Surgical Centers (ASCs); Dermatology Clinics
Subsegments:
1) By Excisional Biopsy: Full-Thickness Excision; Elliptical Excision2) By Incisional Biopsy: Wedge Biopsy; Longitudinal Biopsy; Keyhole Biopsy
3) By Punch Biopsy: 2 Millimeter (mm) Punch; 3-4 Millimeter (mm) Punch; Greater Than Or Equal To (≥) 5 Millimeter (mm) Punch
4) By Shave Biopsy: Tangential Shave; Saucerization Shave; Curved Blade Shave
Companies Mentioned: AccuTec Inc.; Delasco; KAI Medical; Medline Industries; Becton Dickinson and Company; Merit Medical Systems; Cook Medical; Hologic; Olympus Corporation; KARL STORZ; Richard Wolf; ConMed; Integra LifeSciences; Paramount Surgimed; Sklar Instruments; Hu-Friedy; Aesculap; World Precision Instruments; Miltex; Integra Miltex
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Skin Biopsy market report include:- AccuTec Inc.
- Delasco
- KAI Medical
- Medline Industries
- Becton Dickinson and Company
- Merit Medical Systems
- Cook Medical
- Hologic
- Olympus Corporation
- KARL STORZ
- Richard Wolf
- ConMed
- Integra LifeSciences
- Paramount Surgimed
- Sklar Instruments
- Hu-Friedy
- Aesculap
- World Precision Instruments
- Miltex
- Integra Miltex
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.02 Billion |
| Forecasted Market Value ( USD | $ 2.74 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
